viral
infect
import
caus
death
worldwid
unfortun
still
lack
antivir
drug
vaccin
larg
number
virus
repres
remark
challeng
particularli
emerg
reemerg
virus
reason
identif
broad
spectrum
antivir
compound
provid
valuabl
opportun
develop
effici
antivir
therapi
report
class
rhodanin
thiobarbitur
deriv
display
broad
spectrum
antivir
activ
seven
differ
envelop
virus
includ
acyclovir
resist
strain
favor
select
index
due
select
action
envelop
virus
lipid
oxid
abil
hypothes
mechan
viral
envelop
affect
fluiditi
lipid
bilay
thu
compromis
effici
viruscel
fusion
prevent
viral
entri
viral
infect
one
ten
lead
caus
death
worldwid
nowaday
although
effect
antivir
strategi
success
develop
import
pathogen
hiv
hcv
antivir
drug
vaccin
still
miss
major
virus
exampl
effect
antivir
strategi
yet
avail
virus
caus
chronic
infect
hbv
well
tropic
virus
like
dengu
viru
caus
million
infect
per
year
particular
interest
address
recent
epidem
ebola
africa
zika
zikv
south
america
despit
huge
effort
find
antivir
research
commun
abl
execut
time
effici
antivir
plan
major
emerg
reemerg
virus
zoonos
demonstr
passag
among
differ
speci
easier
envelop
virus
comparison
nonenvelop
virus
estim
approxim
unknown
mammalian
virus
anim
reservoir
scenario
possibl
find
antivir
molecul
direct
viral
envelop
particular
interest
order
identifi
broad
spectrum
antivir
drug
previou
paper
report
rhodanin
aminothiazolon
deriv
endow
nanomolar
activ
infect
cell
recent
work
show
compound
also
activ
complet
ineffect
hpv
nonenvelop
viru
result
suggest
mode
action
molecul
could
involv
viral
envelop
compound
act
viral
envelop
previous
describ
rafi
compound
inhibit
broad
rang
envelop
virus
insert
viral
envelop
alter
fusion
kinet
hemifus
stalk
due
invert
cone
structur
liposom
extract
cholesterol
viral
envelop
report
inhibit
hiv
hcv
hbv
virolyt
antivir
peptid
deriv
mastoparan
shown
inhibit
differ
envelop
virus
act
envelop
caus
detach
viral
core
select
strategi
base
fact
viral
envelop
static
character
absenc
repair
mechan
contrast
biogen
membran
cell
endow
plenti
tool
repair
membran
damag
alter
furthermor
sinc
envelop
lipid
deriv
host
cell
complic
viru
develop
resist
compound
compar
target
classic
viral
compon
reason
extrem
promis
target
also
virus
high
mutat
rate
therefor
investig
activ
new
seri
compound
select
potent
deriv
seri
verifi
broad
spectrum
activ
acyclovirresist
strain
six
import
envelop
pathogen
zikv
influenza
viru
iav
respiratori
syncyti
viru
rsv
amongst
other
confirm
complet
inact
three
nonenvelop
virus
final
investig
mechan
action
identifi
lipid
oxid
activ
impair
viral
entri
compound
synthes
use
one
pot
two
step
approach
previous
gener
us
synthesi
rhodanin
deriv
accord
fig
aldehyd
obtain
suzuki
reaction
commerci
avail
iodid
acid
basic
hydrolysi
ester
provid
correspond
acid
nucleophil
substitut
trithiocarbon
opportun
primari
amin
led
rhodanin
intermedi
convert
final
compound
knoevenagel
condens
aldehyd
thiobarbitur
deriv
synthes
shown
fig
reaction
benzoyl
chlorid
ammonium
thiocyan
opportun
amin
led
intermedi
consequ
hydrazinolisi
coupl
reaction
diethylmalon
basic
condit
furnish
monoalkyl
thiobarbitur
deriv
final
knoevenagel
condens
aldehyd
reflux
acid
etoh
led
compound
prove
rhodanin
deriv
belong
seri
compound
potenti
microbicid
activ
investig
inhibitori
activ
novel
deriv
bear
rhodanin
thiobarbitur
scaffold
compound
test
plaqu
effici
assay
preincub
viru
h
subsequ
ad
mixtur
cell
compound
exhibit
potent
inhibitori
activ
noncytotox
dose
demonstr
high
select
index
fig
compound
show
promis
antivir
activ
subject
investig
toxic
compound
evalu
differ
time
point
vero
cell
also
exposur
cc
evalu
confirm
favor
select
index
fig
due
lipophil
natur
compound
result
obtain
previou
work
deriv
seri
prove
effect
hiv
hsv
investig
spectrum
antivir
activ
differ
envelop
virus
ie
hcmv
rsv
zikv
iav
vsv
nonenvelop
virus
ie
hpv
hrov
report
tabl
compound
show
potent
antivir
activ
envelop
virus
test
cytotox
dose
found
inact
nonenvelop
virus
suggest
possibl
action
viral
envelop
interestingli
compound
retain
antivir
activ
also
acyclovir
resist
strain
suggest
differ
mechan
action
perform
assay
aim
better
understand
mechan
action
pretreat
assay
compound
ad
cell
viru
order
determin
antivir
activ
due
interact
cell
moreov
assay
conduct
ad
viru
compound
cell
without
preincub
perform
previou
assay
result
show
fig
demonstr
antivir
activ
due
interact
cell
sinc
compound
activ
pretreat
assay
contrari
observ
signific
reduct
activ
duringinfect
assay
ec
compar
preincub
assay
ec
nm
suggest
loss
activ
could
relat
competit
viral
envelop
cell
membran
insert
activ
compound
investig
whether
compound
abl
inhibit
multipl
cycl
infect
viral
yield
reduct
assay
ad
post
infect
shown
fig
condit
compound
retain
good
antivir
activ
suggest
possibl
therapeut
use
elucid
mechan
action
perform
virucid
assay
incub
viru
concentr
differ
time
fig
serial
dilut
compound
fig
subsequ
mixtur
titrat
cell
viral
titer
evalu
dilut
compound
concentr
known
activ
plaqu
effici
assay
condit
possibl
observ
viral
infect
presenc
compound
decreas
post
treatment
complet
abrog
viru
expos
compound
lower
dose
fig
exposur
nm
fig
irrevers
mechan
also
test
assay
compound
incub
viru
subsequ
mixtur
dilut
drug
free
medium
addit
hour
addit
cell
fig
also
condit
infect
regain
verifi
perman
virucid
activ
sinc
observ
irrevers
effect
exert
differ
stage
viral
infect
investig
detail
compound
produc
physic
disrupt
viru
thu
prevent
attach
cell
success
irrevers
modif
perform
entri
bind
assay
evalu
amount
bound
viru
immunostain
qpcr
result
shown
fig
demonstr
compound
alter
viral
bind
capabl
differ
heparin
known
attach
inhibitor
contrari
entri
assay
perform
possibl
observ
reduct
amount
viru
associ
cell
fig
assay
signal
viru
could
relat
viru
cytoplasm
block
endosom
sinc
treatment
acid
glycin
affect
viru
surfac
cell
reason
perform
also
immunofluoresc
possibl
visual
viru
signal
discret
dot
possibl
endosom
control
viral
signal
diffus
cytoplasm
fig
support
hypothesi
part
viru
could
block
endosom
due
impair
fusion
due
chemic
structur
compound
affin
lipid
envis
mechan
action
might
involv
peroxid
viral
phospholipid
would
lead
alter
fusion
properti
envelop
virus
assess
hypothesi
carri
vitro
lipoperoxid
assay
base
oxid
linol
acid
model
lipid
substrat
incorpor
dppc
liposom
lipid
peroxid
evalu
monitor
product
lipid
degrad
endproduct
malondialdehyd
mda
exposur
compound
linol
acid
underw
remark
lipid
peroxid
liposom
system
fig
result
tba
assay
suggest
peroxid
activ
compound
peroxid
capabl
confirm
reduct
linol
acid
peroxid
extent
control
sampl
prepar
liposom
antioxid
ad
interestingli
addit
ww
work
demonstr
seri
compound
herein
report
particular
compound
endow
broadspectrum
activ
panel
seven
differ
envelop
virus
includ
acyclovir
resist
strain
due
irrevers
mechan
impair
viral
entri
host
cell
select
activ
envelop
virus
lipid
peroxid
capabl
compound
suggest
mechan
action
viral
envelop
affect
viral
cell
membran
fusion
result
open
interest
possibl
applic
molecul
antivir
compon
microbicid
prepar
topic
use
particular
interest
consid
recent
epidem
emerg
reemerg
virus
caus
envelop
virus
ebola
viru
lassa
viru
zika
viru
sar
mer
coronaviru
avian
flu
without
consid
threaten
infect
hendra
nipah
virus
emerg
novel
mutant
strain
final
activ
report
compound
hiv
zikv
transmit
sexual
activ
suggest
possibl
use
class
compound
vagin
microbicid
compon
gener
inform
commerci
avail
chemic
use
purchas
anhydr
reaction
run
posit
pressur
dri
n
thinlay
chromatographi
tlc
carri
use
merck
tlc
plate
silica
gel
chromatograph
purif
perform
column
pack
merck
silica
gel
mesh
flash
techniqu
h
c
nmr
spectra
record
mhz
bruker
avanc
spectromet
melt
point
measur
use
gallenkamp
melt
point
apparatu
uncorrect
microwav
irradi
experi
conduct
use
cem
discov
synthesi
unit
cem
corp
matthew
nc
usa
instrument
consist
continu
focus
microwav
power
deliveri
system
operatorselect
power
output
w
temperatur
content
vessel
monitor
calibr
ir
temperatur
control
mount
reaction
vessel
experi
perform
use
stir
option
wherebi
content
vessel
stir
rotat
magnet
plate
locat
floor
microwav
caviti
teflonco
magnet
stir
bar
vessel
gener
procedur
synthesi
aldehyd
mmol
boron
acid
dissolv
ml
dmf
ml
etoh
reaction
mixtur
stir
min
n
pd
pph
cl
mmol
ad
final
na
co
mmol
reaction
mixtur
lightorang
stir
n
room
temperatur
reaction
went
complet
quench
h
hcl
etoac
ad
mixtur
stir
two
layer
becam
clear
aqueou
layer
extract
three
time
etoac
organ
phase
wash
sever
time
h
brine
dri
na
filter
evapor
reduc
pressur
acid
compound
dissolv
ml
ch
oh
solut
naoh
mmol
ad
dropwis
reaction
mixtur
heat
reflux
reaction
mixtur
stir
overnight
complet
tlc
organ
solvent
remov
reduc
pressur
water
ad
aqueou
layer
extract
three
time
et
aqueou
layer
acidifi
ph
hcl
precipit
appear
gener
procedur
synthesi
compound
benzoylchlorid
mmol
eq
dissolv
ml
aceton
nh
scn
mmol
eq
ad
one
portion
mixtur
irradi
min
microwav
time
opportun
amin
eq
respect
benzylamin
phenethylamin
ad
mixtur
irradi
min
microwav
result
suspens
filter
precipit
wash
h
ch
oh
furnish
pure
white
solid
gener
procedur
synthesi
compound
opportun
thioureido
deriv
mmol
dissolv
ml
hydrazin
monohydr
solut
stir
rt
h
ml
fume
hydrochlor
acid
ad
mixtur
extract
ch
cl
x
ml
organ
phase
wash
na
co
aq
sol
x
ml
dri
na
solvent
remov
reduc
pressur
correspond
residu
purifi
flash
chromatographi
acoetch
cl
gener
procedur
synthesi
compound
sodium
metal
mmol
eq
dissolv
anhydr
etoh
ml
opportun
thiourea
compound
mmol
diethylmalon
mmol
ad
subsequ
mixtur
reflux
argon
atmospher
solvent
remov
reduc
pressur
correspond
residu
solubil
water
mixtur
acidifi
ph
hcl
filter
residu
purifi
flash
chromatographi
ch
cl
ch
oh
dion
yield
red
solid
gener
procedur
synthesi
compound
compound
mmol
eq
compound
mmol
eq
suspend
etoh
ml
drop
hcl
conc
ad
mixtur
stir
overnight
time
ml
hcl
ad
result
precipit
filter
reduc
pressur
give
solid
wash
h
ch
oh
hexan
z
clinic
isol
kindli
provid
prof
pistello
univers
pisa
itali
strain
propag
titrat
plaqu
assay
vero
cell
strain
phenotyp
resist
acyclovir
gener
serial
passag
presenc
increas
concentr
acyclovir
test
acyclovir
resist
doserespons
inhibit
assay
previous
describ
hcmv
strain
town
kindli
provid
prof
w
brune
heinrich
pett
institut
hamburg
germani
propag
titrat
plaqu
assay
helf
cell
rsv
strain
atcc
propag
titrat
indirect
immunoperoxidas
stain
procedur
use
rsv
monoclon
antibodi
abcam
cambridg
unit
kingdom
describ
previous
human
rotaviru
strain
wa
atcc
activ
mgml
porcin
pancreat
trypsin
type
ix
sigma
st
loui
mo
min
propag
cell
use
mem
contain
mg
trypsin
per
ml
describ
previous
vsv
atcc
propag
vero
cell
titrat
plaqu
assay
zika
viru
kindli
provid
marco
alv
propag
titrat
plaqu
assay
vero
cell
iav
isol
clinic
specimen
propag
titrat
mdck
adenoviru
encod
gfp
delet
purchas
vector
biolab
philadelphia
pa
usa
pseudovirion
produc
previous
describ
concentr
assess
hela
cell
viru
stock
maintain
cell
viabil
measur
use
mt
carboxi
methoxi
phenyl
assay
cell
cultur
seed
plate
incub
differ
concentr
compound
duplic
experiment
condit
describ
antivir
assay
ie
incub
time
compound
cell
carri
hour
evalu
antivir
activ
done
later
time
use
cytotox
assay
order
exclud
toxic
effect
antivir
evalu
cell
viabil
determin
use
celltit
prolifer
assay
kit
promega
madison
wi
usa
accord
manufactur
instruct
absorb
measur
use
micropl
reader
model
biorad
nm
effect
cell
viabil
differ
concentr
compound
express
percentag
compar
absorb
treat
cell
cell
incub
cultur
medium
equal
volum
vehicl
cytotox
concentr
cc
confid
interv
ci
determin
use
prism
softwar
graphpad
softwar
san
diego
ca
compound
continu
incub
day
vero
cell
carri
order
evalu
toxic
long
exposur
result
shown
fig
fig
antivir
effect
hsv
vsv
zikv
infect
evalu
plaqu
effici
assay
vero
cell
preplat
h
advanc
plate
densiti
cell
increas
concentr
compound
mix
moi
pfucel
acyclovir
resist
moi
moi
vsv
moi
zikv
moi
incub
hour
mixtur
subsequ
ad
cell
incub
h
viru
inoculum
remov
cell
wash
overlaid
medium
contain
methylcellulos
sigma
incub
h
vsv
h
zikv
cell
fix
stain
crystal
violet
ethanol
viral
plaqu
count
effect
concentr
produc
reduct
plaqu
format
ec
determin
use
prism
softwar
compar
drugtreat
well
treat
medium
solvent
select
index
si
calcul
divid
cc
ec
valu
hcmv
inhibit
assay
helf
cell
preplat
plate
follow
day
increas
concentr
compound
mix
hcmv
moi
incub
h
mixtur
subsequ
ad
cell
incub
h
monolay
wash
overlaid
methylcellulos
medium
supplement
fc
sodium
pyruv
five
day
incub
cell
observ
invert
zeiss
fluoresc
microscop
zeiss
oberkochen
germani
percentag
infect
calcul
compar
gfp
posit
cell
treat
untreat
well
cell
preplat
plate
follow
day
increas
concentr
compound
mix
rsv
moi
incub
h
mixtur
subsequ
ad
cell
incub
h
monolay
wash
overlaid
methylcellulos
medium
h
later
cell
fix
subject
specif
immunostain
use
rsv
monoclon
antibodi
abcam
cambridg
unit
kingdom
order
visual
syncytia
percentag
infect
calcul
compar
number
syncytia
treat
untreat
well
hrov
inhibit
assay
cell
plate
tray
follow
day
viru
infect
activ
ad
porcin
trypsin
sigma
ml
min
increas
concentr
compound
mix
hrov
moi
incub
h
mixtur
subsequ
ad
cell
incub
h
monolay
wash
overlaid
medium
h
cell
fix
cold
acetonemethanol
viral
titer
determin
indirect
immunostain
use
monoclon
antibodi
specif
human
kda
inner
capsid
rotaviru
purchas
covalab
villeurbann
franc
ultratech
hrp
streptavidinbiotin
detect
system
beckman
colter
inhibit
assay
hela
cell
plate
plate
follow
day
increas
concentr
compound
mix
approxim
ngml
moi
incub
h
mixtur
subsequ
ad
cell
incub
h
gfpexpress
infect
cell
observ
invert
zeiss
fluoresc
microscop
zeiss
oberkochen
germani
percentag
infect
calcul
compar
gfp
posit
cell
treat
untreat
well
iav
inhibit
assay
mdck
cell
preplat
plate
follow
day
increas
concentr
compound
mix
iav
moi
incub
h
mixtur
subsequ
ad
cell
h
washout
cell
overlaid
medium
h
cell
fix
subject
specif
immunostain
use
flu
monoclon
antibodi
merck
order
visual
infect
cell
percentag
infect
calcul
compar
number
infect
cell
treat
untreat
well
vero
cell
subject
differ
assay
pretreat
cell
pretreat
h
increas
concentr
compound
inocula
remov
cell
wash
ad
cell
h
subsequ
protocol
describ
follow
infect
cell
subject
experi
describ
without
preincub
compound
viru
post
treatment
cell
infect
moi
h
viral
inoculum
remov
cultur
expos
differ
compound
concentr
incub
control
cultur
display
extens
cytopatholog
supernat
cell
harvest
cellfre
viru
infect
titer
determin
duplic
plaqu
assay
vero
cell
monolay
percent
inhibit
determin
compar
titer
measur
presenc
compound
measur
untreat
well
bind
cell
plate
well
plate
follow
day
compound
moi
incub
h
subsequ
ad
cell
h
cell
fix
paraformaldehyd
air
dri
block
bovin
serum
albumin
bsa
phosphatebuff
salin
pb
tween
bound
viru
detect
use
polyclon
antibodi
dako
denmark
dilut
incub
h
room
temperatur
wash
three
time
pbstween
incub
h
antirabbit
conjug
horseradish
peroxidas
end
incub
plate
wash
three
time
pbstween
abt
benz
thiazolin
sulfon
acid
substrat
ad
min
thermo
scientif
rockford
il
absorb
nm
read
entri
cell
plate
well
plate
follow
day
compound
moi
incub
h
subsequ
ad
cell
h
cell
wash
shift
h
h
subject
wash
acid
glycin
inactiv
unent
viru
cell
fix
paraformaldehyd
air
dri
permeabil
pbstriton
protocol
describ
bind
follow
virucid
assay
approxim
pfu
plu
differ
concentr
compound
ad
mem
mix
total
volum
viruscompound
mixtur
incub
differ
time
dilut
serial
noninhibitori
concentr
test
compound
cell
tube
addit
hour
residu
viral
infect
determin
viral
plaqu
assay
cell
plate
coverslip
follow
day
bind
entri
protocol
describ
appli
cell
fix
paraformaldehyd
air
dri
entri
protocol
permeabil
pbstriton
block
perform
pbsbsa
h
room
temperatur
subsequ
polyclon
antibodi
ad
cell
h
inoculum
remov
coverslip
wash
pbstween
time
rhodamin
conjug
antirabbit
santa
cruz
ad
cell
h
follow
wash
coverslip
mount
microscop
glass
observ
zeiss
fluoresc
microscop
zeiss
oberkochen
germani
imag
acquir
qpcr
cell
subject
bind
assay
lyse
subject
total
dnarna
extract
subsequ
subject
qpcr
use
primer
probe
ccacgagatcaagga
cagcggcctamra
cycl
follow
result
normal
accord
valu
rnasep
bound
viru
measur
compar
treat
well
well
treat
equal
volum
solvent
evalu
oxid
capabl
vitro
lipoperoxid
test
carri
lipid
peroxid
free
radic
attack
doubl
bond
polyunsatur
fatti
acid
form
lipid
hydroperoxid
undergo
homolyt
scission
form
varieti
cytotox
compound
aldehyd
oxid
stress
play
import
role
damag
membran
lipid
accord
previou
literatur
potenti
oxid
effect
evalu
toward
oxid
linol
acid
carboxyl
acid
two
doubl
bond
model
lipid
substrat
lipoperoxid
linol
acid
incorpor
dipalmitoylphosphatidylcholin
dppc
liposom
determin
use
tba
assay
dppc
liposom
prepar
thin
film
evapor
method
use
mimic
phospholipid
bilay
dissolv
linol
acid
tba
assay
commonli
use
index
lipid
peroxid
base
reactiv
malondialdehyd
mda
colourless
endproduct
degrad
acid
tba
produc
pink
adduct
tbamdatba
absorb
nm
mda
inde
one
final
product
polyunsatur
fatti
acid
peroxid
cell
gener
consid
indic
lipid
peroxid
mda
detect
spectrophotometr
accord
method
describ
bay
et
al
follow
modif
tba
compound
dissolv
dmso
concentr
dmso
solut
incub
minut
linol
acid
contain
liposom
aqueou
dispers
blank
sampl
prepar
incub
liposom
aqueou
dispers
either
salin
solut
nacl
aqueou
solut
dmso
absenc
incub
volum
blank
sampl
ml
withdrawn
introduc
glass
tube
close
screw
cap
ad
ml
water
ml
ww
sd
ml
ww
phosphor
acid
ml
ww
tba
mixtur
stir
heat
water
bath
min
favor
format
complex
cool
ice
bath
ml
ad
tube
tbamdatba
complex
extract
upon
stir
centrifug
organ
supernat
evalu
spectrophotometri
calibr
curv
tbamdatba
complex
obtain
use
mda
precursor
mda
obtain
acid
hydrolysi
equimolecular
reaction
purpos
standard
solut
sd
ww
within
concentr
rang
prepar
solut
subject
tba
assay
analyz
spectrophotomet
final
concentr
mda
deriv
reaction
linol
acid
calcul
exploit
calibr
curv
express
micromol
mda
per
mg
lipid
substrat
confirm
oxid
activ
peroxid
experi
also
carri
use
control
sampl
contain
ww
molecul
antioxid
properti
ad
prepar
liposom
mda
format
monitor
condit
report
result
mean
sd
independ
experi
result
present
mean
valu
independ
experi
case
independ
experi
result
express
squar
root
sum
squar
case
sd
ec
valu
inhibit
curv
calcul
regress
analysi
use
softwar
graphpad
prism
graphpad
softwar
san
diego
california
usa
fit
variabl
slopesigmoid
doserespons
curv
bind
entri
assay
signific
analyz
oneway
anova
follow
bonferroni
result
mean
sd
n
docx
